Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA affirmed at 'AA-" by Fitch with stable outlook


Tuesday, 25 Feb 2014 07:01am EST 

Fitch Ratings:Affirms Sanofi SA's ) Long-term Issuer Default Rating (IDR) and senior unsecured rating at 'AA-' and its Short-term IDR at 'F1+.Outlook stable.Says affirmation reflects Sanofi's ability to weather the United States patent expiry of Plavix and Avapro, market positions in pharmaceuticals, vaccines and animal healthcare markets, its well-placed late stage R&D pipeline, financial profile, broad product range and geographical diversification. 

Company Quote

75.98
-1.34 -1.73%
25 Jul 2014